Feb 12, 2026 4:05 pm EST Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Feb 4, 2026 7:00 am EST Rezolute to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Jan 7, 2026 7:00 am EST Rezolute Provides Insights from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism and Shares Findings from its Expanded Access Program in Tumor Hyperinsulinism
Dec 11, 2025 7:00 am EST Rezolute Announces Phase 3 sunRIZE Study Results in Congenital Hyperinsulinism
Nov 6, 2025 4:05 pm EST Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
Sep 17, 2025 4:05 pm EDT Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update
